Jane Street’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-25,108
| Closed | -$153K | – | 11226 |
|
|
2021
Q3 | $153K | Buy |
25,108
+14,976
| +148% | +$93.3K | ﹤0.01% | 9051 |
|
|
2021
Q2 | $83K | Sell |
10,132
-182,398
| -95% | -$1.55M | ﹤0.01% | 9346 |
|
|
2021
Q1 | $1.72M | Buy |
192,530
+149,779
| +350% | +$1.72M | ﹤0.01% | 4314 |
|
|
2020
Q4 | $494K | Buy |
42,751
+12,090
| +39% | +$140K | ﹤0.01% | 5772 |
|
|
2020
Q3 | $319K | Buy |
+30,661
| New | +$376K | ﹤0.01% | 5797 |
|
|
2020
Q1 | – | Sell |
-13,968
| Closed | -$290K | – | 6261 |
|
|
2019
Q4 | $290K | Sell |
13,968
-4,872
| -26% | -$82.2K | ﹤0.01% | 4311 |
|
|
2019
Q3 | $258K | Buy |
18,840
+8,332
| +79% | +$98.9K | ﹤0.01% | 4338 |
|
|
2019
Q2 | $129K | Buy |
+10,508
| New | +$121K | ﹤0.01% | 4806 |
|
|
2018
Q1 | – | Sell |
-14,076
| Closed | -$344K | – | 5647 |
|
|
2017
Q4 | $352K | Buy |
+14,076
| New | +$345K | ﹤0.01% | 3585 |
|
|
2015
Q4 | – | Sell |
-32,593
| Closed | -$484K | – | 4619 |
|
|
2015
Q3 | $484K | Buy |
+32,593
| New | +$765K | ﹤0.01% | 2336 |
|
Jane Street's FLXN Position: Q4 2021 in Review
Jane Street sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 25,108 shares — an estimated $153K sold.
Jane Street first reported a position in FLXN in Q3 2015 and held it in 10 quarters. The position peaked at $1.72M in Q1 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- Jane Street reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- Jane Street sold 25,108 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $153K.
- Jane Street first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 10 quarters.
- Jane Street's Flexion Therapeutics, Inc. position peaked at $1.72M in Q1 2021.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.